UOC
COCH icon

UBS O'Connor’s Envoy Medical COCH Stock Holding History

UBS O'Connor’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-423,516
Closed -$4.28M – 645
2022
Q4 		$4.28M Sell
423,516
-4,144
-1% -$41.2K 0.08% 233
2022
Q3 		$4.2M Sell
427,660
-42,813
-9% -$420K 0.05% 344
2022
Q2 		$4.61M Hold
470,473
– – 0.05% 345
2022
Q1 		$4.6M Buy
470,473
+8,291
+2% +$80.7K 0.05% 314
2021
Q4 		$4.51M Buy
462,182
+12,378
+3% +$121K 0.04% 310
2021
Q3 		$4.36M Hold
449,804
– – 0.03% 337
2021
Q2 		$4.36M Buy
+449,804
New +$4.37M 0.04% 302

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS O'Connor's COCH Position: Q1 2023 in Review

UBS O'Connor sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 423,516 shares — an estimated $4.28M sold.

UBS O'Connor first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $4.61M in Q2 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • UBS O'Connor reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 423,516 Envoy Medical shares in Q1 2023, an estimated $4.28M.
  • UBS O'Connor first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • UBS O'Connor's Envoy Medical position peaked at $4.61M in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.